JP2023537518A5 - - Google Patents
Info
- Publication number
- JP2023537518A5 JP2023537518A5 JP2023509430A JP2023509430A JP2023537518A5 JP 2023537518 A5 JP2023537518 A5 JP 2023537518A5 JP 2023509430 A JP2023509430 A JP 2023509430A JP 2023509430 A JP2023509430 A JP 2023509430A JP 2023537518 A5 JP2023537518 A5 JP 2023537518A5
- Authority
- JP
- Japan
- Prior art keywords
- ebola virus
- gpδmuc
- sequence
- ebov
- protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063063530P | 2020-08-10 | 2020-08-10 | |
| US63/063,530 | 2020-08-10 | ||
| PCT/US2021/045178 WO2022035739A2 (en) | 2020-08-10 | 2021-08-09 | Compositions and methods related to ebola virusvaccines |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023537518A JP2023537518A (ja) | 2023-09-01 |
| JP2023537518A5 true JP2023537518A5 (https=) | 2024-12-27 |
| JP7631502B2 JP7631502B2 (ja) | 2025-02-18 |
Family
ID=80114705
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023509430A Active JP7631502B2 (ja) | 2020-08-10 | 2021-08-09 | エボラウイルスワクチンに関連する組成物及び方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US11305004B2 (https=) |
| EP (1) | EP4192500A4 (https=) |
| JP (1) | JP7631502B2 (https=) |
| CN (1) | CN116472278A (https=) |
| AU (1) | AU2021324954A1 (https=) |
| CA (1) | CA3190148A1 (https=) |
| IL (1) | IL300527A (https=) |
| MX (1) | MX2023001433A (https=) |
| WO (1) | WO2022035739A2 (https=) |
| ZA (1) | ZA202301221B (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024130061A1 (en) * | 2022-12-16 | 2024-06-20 | Cz Biohub Sf, Llc | Immunogenic ebolavirus fusion proteins and related methods |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7211378B2 (en) * | 2002-01-31 | 2007-05-01 | Wisconsin Alumni Research Foundation | Filovirus vectors and noninfectious filovirus-based particles |
| GB201502209D0 (en) * | 2015-02-10 | 2015-03-25 | Sec Dep For Health The And Chancellor Masters And Scholars Of The University Of Oxford The And Micro | Filovirus therapy |
| WO2016145385A2 (en) | 2015-03-11 | 2016-09-15 | Integrated Biotherapeutics, Inc. | Pan-ebola and pan-filovirus protective epitopes, antibodies, and antibody cocktails |
| US11135280B2 (en) * | 2016-03-28 | 2021-10-05 | Integrated Biotherapeutics, Inc. | Modified ebolavirus glycoproteins comprising mutations in the head and base domains that increase antibody cross-reactivity |
| KR20260047644A (ko) * | 2017-03-30 | 2026-04-08 | 더 유니버서티 어브 퀸슬랜드 | 키메라 분자 및 그의 용도 |
| CN107034225B (zh) * | 2017-05-04 | 2020-01-17 | 中国人民解放军军事医学科学院生物工程研究所 | 制备埃博拉病毒糖蛋白与基质蛋白融合突变体的方法 |
| WO2019241483A1 (en) | 2018-06-13 | 2019-12-19 | The Scripps Research Institute | Nanoparticle vaccines with novel structural components |
| CA3107083A1 (en) * | 2018-08-13 | 2020-02-20 | Janssen Vaccines & Prevention B.V. | Stabilized filovirus glycoprotein trimers |
-
2021
- 2021-08-09 WO PCT/US2021/045178 patent/WO2022035739A2/en not_active Ceased
- 2021-08-09 EP EP21856499.5A patent/EP4192500A4/en active Pending
- 2021-08-09 CN CN202180069178.XA patent/CN116472278A/zh active Pending
- 2021-08-09 CA CA3190148A patent/CA3190148A1/en active Pending
- 2021-08-09 MX MX2023001433A patent/MX2023001433A/es unknown
- 2021-08-09 JP JP2023509430A patent/JP7631502B2/ja active Active
- 2021-08-09 US US17/397,340 patent/US11305004B2/en active Active
- 2021-08-09 AU AU2021324954A patent/AU2021324954A1/en not_active Abandoned
- 2021-08-09 IL IL300527A patent/IL300527A/en unknown
-
2022
- 2022-04-07 US US17/715,658 patent/US11872277B2/en active Active
-
2023
- 2023-01-30 ZA ZA2023/01221A patent/ZA202301221B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7555826B2 (ja) | 新規構造成分を含有するナノ粒子ワクチン | |
| JP2023533228A (ja) | 安定化コロナウイルススパイク（ｓ）タンパク質免疫原および関連ワクチン | |
| US20230190910A1 (en) | Scaffolded hiv-1 vaccine immunogens | |
| KR20160002938A (ko) | 안정화된 가용성 예비융합 ｒｓｖ ｆ 폴리펩타이드 | |
| JP2019522626A (ja) | Ｈｉｖ−１免疫原に関連した組成物および方法 | |
| US20230034467A1 (en) | Engineered HCV E2 Immunogens and Related Vaccine Compositions | |
| JP7631502B2 (ja) | エボラウイルスワクチンに関連する組成物及び方法 | |
| JP2023537518A5 (https=) | ||
| KR20140135771A (ko) | Hiv-1 gp41 프리-헤어핀 중간체의 안정한 펩티드 모방체 | |
| EA050680B1 (ru) | Композиции и способы, связанные с вакцинами против эболавируса | |
| WO2025144636A1 (en) | ENGINEERED hMPV F PROTEIN IMMUNOGENS AND RELATED VACCINES | |
| CN120435313A (zh) | 包含新的纳米粒支架的疫苗 | |
| EA046652B1 (ru) | Вакцины на основе наночастиц с новыми структурными компонентами | |
| EA041182B1 (ru) | Композиции и способы, связанные с иммуногенами вич-1 |